Paul Gyseman looks at the insurance implications of this oesophageal condition and why underwriters need to be alert when assessing the long-term risks of this common disclosure
“What a feeling” sings the female police officer as she directs traffic in the TV advert for Gaviscon. Well, that ‘feeling’ she is singing about is the relief that certain medications bring to the symptoms of gastro-oesophageal reflux, commonly known as heartburn or indigestion, which cause misery to many people on a daily basis. Barrett’s oesophagus is a long-term complication of gastro-oesophageal reflux disease (GORD), which is a common disclosure on insurance applications and often mentioned in medical reports. Cause of illness Barrett’s oesophagus is generally caused by long...
To continue reading this article...
Join Professional Adviser
- Unlimited access to real-time news, industry insights and market intelligence.
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters.
- Make smart business decisions with the latest developments in regulation, investing retirement and protection.
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes.